⁶⁴Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment.

This article reports a facile synthesis of radiolabeled PdCu@Au core-shell tripods for use in positron emission tomography (PET) and image-guided photothermal cancer treatment by directly incorporating radioactive (64)Cu atoms into the crystal lattice. The tripod had a unique morphology determined by the PdCu tripod that served as a template for the coating of Au shell, in addition to well-controlled specific activity and physical dimensions. The Au shell provided the nanostructure with strong absorption in the near-infrared region and effectively prevented the Cu and (64)Cu atoms in the core from oxidization and dissolution. When conjugated with D-Ala1-peptide T-amide (DAPTA), the core-shell tripods showed great enhancement in targeting the C-C chemokine receptor 5 (CCR5), a newly identified theranostic target up-regulated in triple negative breast cancer (TNBC). Specifically, the CCR5-targeted tripods with an arm length of about 45 nm showed 2- and 6-fold increase in tumor-to-blood and tumor-to-muscle uptake ratios, respectively, relative to their nontargeted counterpart in an orthotopic mouse 4T1 TNBC model at 24 h postinjection. The targeting specificity was further validated via a competitive receptor blocking study. We also demonstrated the use of these targeted, radioactive tripods for effective photothermal treatment in the 4T1 tumor model as guided by PET imaging. The efficacy of treatment was confirmed by the significant reduction in tumor metabolic activity revealed through the use of (18)F-fluorodeoxyglucose PET/CT imaging. Taken together, we believe that the (64)Cu-doped PdCu@Au tripods could serve as a multifunctional platform for both PET imaging and image-guided photothermal cancer therapy.

[1]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Jun Zhao,et al.  Cancer theranostics with gold nanoshells. , 2014, Nanomedicine.

[3]  M. Watanabe,et al.  Molecular Markers for Breast Cancer: Prediction on Tumor Behavior , 2014, Disease markers.

[4]  Erik C. Dreaden,et al.  The Golden Age: Gold Nanoparticles for Biomedicine , 2012 .

[5]  J. G. Solé,et al.  Nanoparticles for photothermal therapies. , 2014, Nanoscale.

[6]  Mostafa A. El-Sayed,et al.  Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method , 2003 .

[7]  Younan Xia,et al.  Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. , 2012, ACS nano.

[8]  Xiaohua Huang,et al.  Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. , 2008, Accounts of chemical research.

[9]  N. Skelton,et al.  Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.

[10]  Karen L Wooley,et al.  Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. , 2014, Angewandte Chemie.

[11]  S. Sukumar,et al.  Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis , 2014, Nature Communications.

[12]  Younan Xia,et al.  Gold Nanomaterials at Work in Biomedicine. , 2015, Chemical reviews.

[13]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[14]  Younan Xia,et al.  Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. , 2013, Nano letters.

[15]  S. Wise.  Nanocarriers as an emerging platform for cancer therapy , 2007 .

[16]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[17]  M. Lisanti,et al.  CCR5 antagonist blocks metastasis of basal breast cancer cells. , 2012, Cancer research.

[18]  G. Semenza,et al.  Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment , 2014, Proceedings of the National Academy of Sciences.

[19]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[20]  Hong Yuan,et al.  Specific photothermal therapy to the tumors with high EphB4 receptor expression. , 2015, Biomaterials.

[21]  Younan Xia,et al.  Pd–Cu Bimetallic Tripods: A Mechanistic Understanding of the Synthesis and Their Enhanced Electrocatalytic Activity for Formic Acid Oxidation , 2014 .

[22]  Xin Cai,et al.  Radioactive 198Au-Doped Nanostructures with Different Shapes for In Vivo Analyses of Their Biodistribution, Tumor Uptake, and Intratumoral Distribution , 2014, ACS nano.

[23]  Y. Ozaki,et al.  Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  A. Ben-Baruch,et al.  The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients , 2006, Clinical Cancer Research.

[25]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[26]  L. Liz‐Marzán,et al.  Surface enhanced Raman scattering using star-shaped gold colloidal nanoparticles , 2010 .

[27]  A. Ulman,et al.  Formation and Structure of Self-Assembled Monolayers. , 1996, Chemical reviews.

[28]  Younan Xia,et al.  Gold nanocages as photothermal transducers for cancer treatment. , 2010, Small.

[29]  R. Pestell,et al.  The CCL5/CCR5 axis promotes metastasis in basal breast cancer , 2013, Oncoimmunology.

[30]  Naomi J. Halas,et al.  Nanoengineering of optical resonances , 1998 .

[31]  Younan Xia,et al.  Gold nanostructures: a class of multifunctional materials for biomedical applications. , 2011, Chemical Society reviews.

[32]  A. Ben-Baruch,et al.  The inflammatory chemokines CCL2 and CCL5 in breast cancer. , 2008, Cancer letters.

[33]  Younan Xia,et al.  Engineered Nanoparticles for Drug Delivery in Cancer Therapy * , 2015, Nanomaterials and Neoplasms.

[34]  Eric D. Pressly,et al.  PET/CT Imaging of Chemokine Receptor CCR5 in Vascular Injury Model Using Targeted Nanoparticle , 2014, The Journal of Nuclear Medicine.

[35]  Mostafa A. El-Sayed,et al.  The golden age: gold nanoparticles for biomedicine. , 2012, Chemical Society reviews.

[36]  Sungjee Kim,et al.  Gold nanoparticle-mediated photothermal therapy: current status and future perspective. , 2014, Nanomedicine.

[37]  Dingbin Liu,et al.  Chelator-Free 64Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy , 2014, ACS nano.

[38]  D. Mankoff,et al.  Advances in molecular imaging for breast cancer detection and characterization , 2012, Breast Cancer Research.

[39]  M. Labelle,et al.  Molecular classification of infiltrating breast cancer: toward personalized therapy. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[40]  Younan Xia,et al.  Gold Nanostructures: Engineering Their Plasmonic Properties for Biomedical Applications , 2007 .

[41]  Younan Xia,et al.  Shape‐Controlled Synthesis of Gold and Silver Nanoparticles. , 2003 .

[42]  R. Pestell,et al.  The potential to target CCL5/CCR5 in breast cancer , 2014, Expert opinion on therapeutic targets.

[43]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[44]  M. Weil,et al.  The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. , 2002, Cancer research.

[45]  Peter Nordlander,et al.  Optical properties of metallodielectric nanostructures calculated using the finite difference time domain method , 2004 .

[46]  Meenakshi Singh,et al.  Triple-negative breast carcinoma: current and emerging concepts. , 2014, American journal of clinical pathology.

[47]  Xin Cai,et al.  Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. , 2013, ACS nano.

[48]  Younan Xia,et al.  Measuring the Optical Absorption Cross-sections of Au-Ag Nanocages and Au Nanorods by Photoacoustic Imaging. , 2009, The journal of physical chemistry. C, Nanomaterials and interfaces.

[49]  Na Li,et al.  Anisotropic gold nanoparticles: synthesis, properties, applications, and toxicity. , 2014, Angewandte Chemie.

[50]  David A Mankoff,et al.  Tumor Receptor Imaging , 2008, Journal of Nuclear Medicine.

[51]  Jesse V. Jokerst,et al.  Construction and Validation of Nano Gold Tripods for Molecular Imaging of Living Subjects , 2014, Journal of the American Chemical Society.

[52]  Yongjian Liu,et al.  Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters. , 2014, Nanoscale.